SUVEN PHARMACEUTICALS
|
The Current P/S Ratio of SUVEN PHARMACEUTICALS is 26.86.
Share Price | ₹1,014.1 | Jan 29,2025 |
Market Cap | ₹25,817.7 Cr | |
Sales-TTM | ₹961.2 Cr | TTM-Consolidated Results |
Price/Sales | 26.86x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SUVEN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹25,817.7 Cr] as on Jan 29,2025
(/) Sales [ ₹961.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 26.86x ]
Thus, for SUVEN PHARMACEUTICALS , the investors are currently willing to pay '26.86 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SUVEN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SUVEN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SUVEN PHARMACEUTICALS
PS Ratio Performance Analysis for SUVEN PHARMACEUTICALS
- SUVEN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 10.57x.
- SUVEN PHARMACEUTICALS 's operated at median p/e ratio of 11.92x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUVEN PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 16.38x.
- SUVEN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 3.08x.
How does SUVEN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SUVEN PHARMACEUTICALS | 961.2 | 26.86 | 25,817.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.28 | 416,692.0 |
CIPLA LTD | 26,981.2 | 4.26 | 115,000.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.16 | 98,616.4 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.37 | 93,841.4 |
DIVIS LABORATORIES LTD | 8,614.0 | 17.32 | 149,215.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.78 | 102,232.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 10.06 | 113,701.0 |
LUPIN LTD | 21,431.3 | 4.40 | 94,337.9 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.22 | 67,192.9 |
ABBOTT INDIA LTD | 6,066.1 | 8.92 | 54,136.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SUVEN PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.22x |
Max industry PS | 26.86x |
Median industry PS | 8.28x |
Average industry PS | 8.97x |
You may also like the below Video Courses